'Market Realizing That Endp Is The Real Beneficiary Of Opioid Settlement As Reported Fundamentals Have Improved Since Stock Was At $18 A Year Ago. Low Or No Cash Payout.Good Fcf, Bal Sheet, And Strong Pipeline. If Reporting Is True ENDP Can Be $10 On MNK' -Citron Research
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.